ROBIN MCBRIDE: Open Payments
NPI 1912662735 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$148 in 4 payments from 4 companies in 2025. Trend: 2023 $259 · 2024 $96 · 2025 $148
Food & beverage: $148
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $46 |
| Stemline Therapeutics Inc. | 1 | $39 |
| Geron Corporation | 1 | $34 |
| ADC THERAPEUTICS AMERICA, INC. | 1 | $29 |
Products named: FRUZAQLA, Orserdu, RYTELO, ZYNLONTA.
Industry payments across CA — which companies pay providers there.
